Cargando…

Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis

OBJECTIVES: Chemoradiotherapy (CRT) has been the backbone of guideline-recommended treatment for Stage IIIA non-small cell lung cancer (NSCLC). However, in selected operable patients with a resectable tumour, good results have been achieved with trimodality treatment (TT). The objective of this bi-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joosten, Pieter J M, Dickhoff, Chris, van der Noort, Vincent, Smeekens, Maarten, Numan, Rachel C, Klomp, Houke M, van Diessen, Judi N A, Belderbos, Jose S A, Smit, Egbert F, Monkhorst, Kim, Oosterhuis, Jan W A, van den Heuvel, Michel M, Dahele, Max, Hartemink, Koen J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Thoracic
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972331/ https://www.ncbi.nlm.nih.gov/pubmed/34734237 http://dx.doi.org/10.1093/icvts/ivab291

Ejemplares similares

Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapy
por: Tang, Andrew, et al.
Publicado: (2022)

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients
por: Vessies, Daan C. L., et al.
Publicado: (2022)

Early results of a trimodality treatment for superior sulcus tumors
por: Łapiński, Mariusz, et al.
Publicado: (2014)

Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy
por: Watanabe, Kenji, et al.
Publicado: (2023)

Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
por: Dan, Aravot, et al.
Publicado: (2019)

Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
por: Aravot, Dan, et al.
Publicado: (2019)

Variation in incidence, prevention and treatment of persistent air leak after lung cancer surgery
por: Hoeijmakers, Fieke, et al.
Publicado: (2021)

Salvage Surgery for Patients With Local Recurrence or Persistent Disease After Treatment With Chemoradiotherapy for SCLC
por: Joosten, Pieter J.M., et al.
Publicado: (2021)

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions
por: Hummelink, Karlijn, et al.
Publicado: (2019)

Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer
por: Jeremić, Branislav, et al.
Publicado: (2018)

Challenges in the target volume definition of lung cancer radiotherapy
por: Mercieca, Susan, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells Using the Attune NxT
por: Gruijs, Mandy, et al.
Publicado: (2022)

Staged single-port thoracoscopic R2 sympathicotomy as a reproducible, safe and effective treatment option for debilitating severe facial blushing
por: van der Weijde, Emma, et al.
Publicado: (2022)

Part-solid tumours: at the border of 2 worlds
por: Van Schil, Paul E, et al.
Publicado: (2021)

Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery
por: ten Berge, Martijn G, et al.
Publicado: (2020)

Trimodal therapy in squamous cell carcinoma of the esophagus
por: Matuschek, C, et al.
Publicado: (2011)

Personalized trimodal prehabilitation for gastrectomy
por: Bausys, Augustinas, et al.
Publicado: (2020)

The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy
por: Yang, Hui, et al.
Publicado: (2021)

Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey
por: van Rijswijk, A. S., et al.
Publicado: (2019)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Bipolar disorder: Trimodal age‐at‐onset distribution
por: Bolton, Sorcha, et al.
Publicado: (2020)

Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP)
por: Jezerskyte, E., et al.
Publicado: (2021)

Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer
por: Faiz, Z., et al.
Publicado: (2019)

Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses
por: van Kooten, Robert T., et al.
Publicado: (2021)

Extended, virtual and augmented reality in thoracic surgery: a systematic review
por: Arjomandi Rad, Arian, et al.
Publicado: (2021)

Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib
por: Wicherts, Dennis A, et al.
Publicado: (2013)

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
por: Schreurs, L. M. A., et al.
Publicado: (2011)

Lung transplantation in patients with a history of anatomical native lung resection
por: Iskender, Ilker, et al.
Publicado: (2022)

Anaplastic thyroid cancer: outcomes of trimodal therapy
por: Houlihan, Orla A., et al.
Publicado: (2021)

Prediction of phenotypic severity in mucopolysaccharidosis type IIIA
por: Knottnerus, Suzan J. G., et al.
Publicado: (2017)

Preoperative visualization of congenital lung abnormalities: hybridizing artificial intelligence and virtual reality
por: Bakhuis, Wouter, et al.
Publicado: (2023)

Thymolipomatous myasthenia gravis outcomes following thymectomy: a systematic review
por: Alghamdi, Zeead M, et al.
Publicado: (2021)

Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy
por: Defize, I. L., et al.
Publicado: (2020)

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy
por: Hulshoff, J. B., et al.
Publicado: (2015)

Quality of Life During and After Completion of Neoadjuvant Chemoradiotherapy for Esophageal and Junctional Cancer
por: Noordman, B. J., et al.
Publicado: (2019)

Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?
por: van Joolingen, W. Hugo, et al.
Publicado: (2021)

Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project(†)
por: Moser, Bernhard, et al.
Publicado: (2017)

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
por: Hoek, Jantien, et al.
Publicado: (2016)

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
por: Mazieres, J., et al.
Publicado: (2019)

Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus Tumors
por: Ünal, S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iseiu734h4qhbq3cdee5ssecfc